Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163–96.
McConnell RC, Fleischer AB Jr, Williford PM, et al. Most topical tretinoin treatment is for acne vulgaris through the age of 44 years: an analysis of the National Ambulatory Medical Care Survey, 1990–1994. J Am Acad Dermatol. 1998;38:221–6.
Collier CN, Harper JC, Cafardi JA, et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008;58:56–9.
Moradi Tuchayi S, Makrantonaki E, Ganceviciene R, et al. Acne vulgaris. Nat Rev Dis Primers. 2015;1:15029.
Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74:945–73.
Nast A, Dreno B, Bettoli V, et al. European evidence-based (S3) guideline for the treatment of acne: update 2016: short version. J Eur Acad Dermatol Venereol. 2016;30:1261–8.
Del Rosso JQ, Bikowski JB, Baum E, et al. A closer look at truncal acne vulgaris: prevalence, severity, and clinical significance. J Drugs Dermatol. 2007;6:597–600.
Del Rosso JQ, Stein-Gold L, Lynde C, et al. Truncal acne: a neglected entity. J Drugs Dermatol. 2019;18:205–1208.
Tan J, Beissert S, Cook-Bolden F, et al. Impact of facial and truncal acne on quality of life: a multi-country population-based survey. JAAD Int. 2021;3:102–10.
Papadopoulos L, Walker C, Aitken D, Bor R. The relationship between body location and psychological morbidity in individuals with acne vulgaris. Psychol Health Med. 2000;5:431–8.
Hassan J, Grogan S, Clark-Carter D, et al. The individual health burden of acne: appearance-related distress in male and female adolescents and adults with back, chest and facial acne. J Health Psychol. 2009;14:1105–18.
Tan JJK, Tang J, Fung K, et al. Prevalence and severity of facial and truncal acne in a referral cohort. J Drugs Dermatol. 2008;7:551–6.
Dreno B, Jean-Decoster C, Georgescu V. Profile of patients with mild-to-moderate acne in Europe: a survey. Eur J Dermatol. 2016;26:177–84.
Goncalves G, Amado JM, Matos ME, et al. The prevalence of acne among a group of Portuguese medical students. J Eur Acad Dermatol Venereol. 2012;6:514–7.
Tan J, Del Rosso JQ, Weiss JS, et al. Prevalence and demographics of truncal involvement among acne patients: survey data and a review of the literature. J Clin Aesthet Dermatol. 2022;15:62–7.
Isaacsson VC, Almeida JRHL, Duquia RP, et al. Dissatisfaction and acne vulgaris in male adolescents and associated factors. An Bras Dermatol. 2014;89:576–9.
Dreno B, Thiboutot D, Layton AM, et al. Large-scale international study enhances understanding of an emerging acne population: adult females. J Eur Acad Dermatol Venereol. 2015;29:1096–106.
Radi R, Gold S, Acosta JP, et al. Treating acne in transgender persons receiving testosterone: a practical guide. Am J Clin Dermatol. 2022;23:219–29.
Wierckx K, Van de Peer F, Verhaeghe E, et al. Short- and long-term clinical skin effects of testosterone treatment in trans men. J Sex Med. 2014;11:222–9.
Plewig G, Melnik B, Chen W. Acne-mimicking diseases, Plewig and Kligman’s acne and rosacea. Cham: Springer International Publishing; 2019. p. 299–410.
Wu DC, Chan WW, Metelitsa AI, et al. Pseudomonas skin infection: clinical features, epidemiology, and management. Am J Clin Dermatol. 2011;12:157–69.
Boni R, Nehrhoff B. Treatment of gram-negative folliculitis in patients with acne. Am J Clin Dermatol. 2003;4:273–6.
Luelmo-Aguilar J, Santandreu MS. Folliculitis: recognition and management. Am J Clin Dermatol. 2004;5:301–10.
Back O, Faergemann J, Hornqvist R. Pityrosporum folliculitis: a common disease of the young and middle-aged. J Am Acad Dermatol. 1985;12:56–61.
Ayers K, Sweeney SM, Wiss K. Pityrosporum folliculitis: diagnosis and management in 6 female adolescents with acne vulgaris. Arch Pediatr Adolesc Med. 2005;159:64–7.
Ponka D, Baddar F. Wood lamp examination. Can Fam Physician. 2012;58:976.
Durdu M, Guran M, Ilkit M. Epidemiological characteristics of Malassezia folliculitis and use of the May-Grunwald-Giemsa stain to diagnose the infection. Diagn Microbiol Infect Dis. 2013;76:450–7.
Poli F. Differential diagnosis of facial acne on black skin. Int J Dermatol. 2012;51(24–26):27–9.
Jacinto-Jamora S, Tamesis J, Katigbak ML. Pityrosporum folliculitis in the Philippines: diagnosis, prevalence, and management. J Am Acad Dermatol. 1991;24:693–6.
Hald M, Arendrup MC, Svejgaard EL, et al. Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases. Acta Derm Venereol. 2015;95:12–9.
Rosenthal D, LeBoit PE, Klumpp L, et al. Human immunodeficiency virus-associated eosinophilic folliculitis: a unique dermatosis associated with advanced human immunodeficiency virus infection. Arch Dermatol. 1991;127:206–9.
Parker SR, Parker DC, McCall CO. Eosinophilic folliculitis in HIV-infected women: case series and review. Am J Clin Dermatol. 2006;7:193–200.
Bull RH, Harland CA, Fallowfield ME, et al. Eosinophilic folliculitis: a self-limiting illness in patients being treated for haematological malignancy. Br J Dermatol. 1993;129:178–82.
Evans TR, Mansi JL, Bull R, et al. Eosinophilic folliculitis occurring after bone marrow autograft in a patient with non-Hodgkin’s lymphoma. Cancer. 1994;73:2512–4.
Teraki Y, Konohana I, Shiohara T, et al. Eosinophilic pustular folliculitis (Ofuji’s disease): immunohistochemical analysis. Arch Dermatol. 1993;129:1015–9.
Ellis E, Scheinfeld N. Eosinophilic pustular folliculitis: a comprehensive review of treatment options. Am J Clin Dermatol. 2004;5:189–97.
Paichitrojjana A. Demodicosis imitating acne vulgaris: a case report. Clin Cosmet Investig Dermatol. 2022;15:497–501.
Chen W, Plewig G. Human demodicosis: revisit and a proposed classification. Br J Dermatol. 2014;170:1219–25.
Forton F, Seys B. Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Br J Dermatol. 1993;128:650–9.
Huang HP, Hsu CK, Lee JY. A new superficial needle-scraping method for assessing Demodex density in papulopustular rosacea. J Cosmet Dermatol. 2020;19:896–900.
Aktas Karabay E, Aksu CA. Demodex folliculorum infestations in common facial dermatoses: acne vulgaris, rosacea, seborrheic dermatitis. An Bras Dermatol. 2020;95:187–93.
Salem DA, El-Shazly A, Nabih N, et al. Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum. Int J Infect Dis. 2013;17:e343–7.
Sarac G. A comparison of the efficacy and tolerability of topical agents used in facial Demodex treatment. J Cosmet Dermatol. 2019;18:1784–7.
Bikowski JB, Del Rosso JQ. Demodex dermatitis: a retrospective analysis of clinical diagnosis and successful treatment with topical crotamiton. J Clin Aesthet Dermatol. 2009;2:20–5.
Jacot W, Bessis D, Jorda E, et al. Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours. Br J Dermatol. 2004;151:238–41.
Hurwitz RM. Steroid acne. J Am Acad Dermatol. 1989;21:1179–81.
Nielsen JN, Licht RW, Fogh K. Two cases of acneiform eruption associated with lamotrigine. J Clin Psychiatry. 2004;65:1720–2.
Yeung CK, Chan HH. Cutaneous adverse effects of lithium: epidemiology and management. Am J Clin Dermatol. 2004;5:3–8.
Bieber T, Simpson EL, Silverberg JI, et al. Abrocitinib versus placebo or dupilumab for atopic dermatitis. N Engl J Med. 2021;384:1101–12.
Kazandjieva J, Tsankov N. Drug-induced acne. Clin Dermatol. 2017;35:156–62.
Du-Thanh A, Kluger N, Bensalleh H, et al. Drug-induced acneiform eruption. Am J Clin Dermatol. 2011;12:233–45.
留言 (0)